Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/18/2025

Melatonin Use During Pregnancy: Safety and Guidelines

Introduction to Melatonin Safety

  • The American College of Obstetricians and Gynecologists implies that melatonin may be considered for sleep disorders during pregnancy, starting with the lowest effective dose (1-3 mg), as lower doses may be more effective than higher doses due to receptor saturation concerns 1
  • The American Academy of Sleep Medicine suggests administering melatonin 1.5-2 hours before desired bedtime for optimal circadian effect 1

Practical Considerations for Melatonin Use

  • The National Institutes of Health recommends choosing United States Pharmacopeial Convention Verified formulations for reliable dosing and purity, as melatonin is regulated as a dietary supplement with variable quality 1, 2
  • The American College of Obstetricians and Gynecologists advises considering non-pharmacological sleep interventions first, particularly in early pregnancy when organogenesis occurs 2

Important Safety Precautions

  • The American Heart Association recommends using caution in pregnant patients taking warfarin due to potential interactions 2
  • The Endocrine Society suggests monitoring for impaired glucose tolerance, as melatonin has been associated with this in healthy individuals after acute administration 2
  • The American Psychiatric Association advises avoiding use if there is personal or family history of psychiatric disorder, as melatonin has been associated with increased depressive symptoms in some individuals 2

Comparison to Other Medications

  • The American Diabetes Association states that ACE inhibitors and ARBs are contraindicated during pregnancy due to documented fetal harm 3, 4
  • The American College of Cardiology recommends that statins should generally be avoided but can be considered in high-risk cases through shared decision-making 3
  • The American Academy of Pediatrics suggests that ADHD stimulant medications show very low magnitude of documented risks, and consensus supports not stopping them if required for daily functioning 5, 6